American Hospital Formulary Service, pp. 379, 412, 1985.
2.
Barlock, A.; Howser, D. and Hubbard, S.Nursing management of Adriamycin extravasation. Am. J. Nurs. , 79:1:94-96, January, 1979.
3.
Bowers, D. and Lynch, J.Adriamycin extravasation. Plast. Reconstr. Surg., 61:1:86-92, January, 1978.
4.
Dorr, R.; Alberts, D.; and Stone, A.Cold protection and heat enhancement of Doxorubicin skin toxicity in the mouse . Cancer Treat. Rep., 69:4:431-437, April 1985.
5.
Dorr, R. and Alberts, D.Vinca alkaloid skin toxicity: Antidote and drug disposition studies in the mouse. JNCI, 74:1:113-120, January, 1985.
6.
Harwood, K.V. and Aisner, J.A.Treatment of chemotherapy extravasations . Cancer Treat. Rep., 68:7-8:939-945, July/August, 1984 .
7.
Ingnoffo, R.J. and Friedman, M.A.Therapy of local toxicities caused by extravasation of cancer chemotherapeutic agents. Cancer Treat Rev.. 7:17-27, 1980.
8.
Larson, D.L.Treatment of tissue extravasation by antitumor agentsCancer49:9:1796-1799, May 1, 1982.
9.
Oncology Nursing Society.Cancer Chemotherapy Guidelines and Recommendations for Nursing Education and Practice, pp. 12-17, 1984.
10.
Reilly, J.; Neifeld, J.; and Rosenberg, S.A.Clinical course and management of accidental Adriamycin extravasation . Cancer, 40:2053-2056, 1972 .
11.
Rudolph, R.; Stein, R.; and Patillo, R.Skin ulcers due to Adriamycin. Cancer, 38:3:1087-1094, September, 1976 .
12.
Wang, J.J., et al. Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease. Cancer, 28:4:837-843, October, 1971.
13.
Wood, H.A. andEllerhorst-Ryna, J. Delayed adverse skin reactions associated with Mitomycin-C administration. Oncol. Nurs. Forum . 11:4:14-18, July/August, 1984.
14.
Yasko, J.Guidelines for Cancer Cure-Symptom Management: Reston, Virginia: Reston Publishing, 1983 .
